|
NAMPT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.503810E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.361700E-03 |
| Normal-vs-Stage2 |
7.771000E-01 |
| Normal-vs-Stage3 |
6.101100E-03 |
| Normal-vs-Stage4 |
1.660760E-03 |
| Stage1-vs-Stage2 |
5.868000E-02 |
| Stage1-vs-Stage3 |
9.007600E-01 |
| Stage1-vs-Stage4 |
2.539400E-01 |
| Stage2-vs-Stage3 |
5.869800E-02 |
| Stage2-vs-Stage4 |
1.569780E-02 |
| Stage3-vs-Stage4 |
3.154800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.833460E-04 |
| Normal-vs-AfricanAmerican |
4.552100E-02 |
| Normal-vs-Asian |
4.102800E-01 |
| Caucasian-vs-AfricanAmerican |
5.176400E-01 |
| Caucasian-vs-Asian |
7.040800E-03 |
| AfricanAmerican-vs-Asian |
9.971500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.748300E-02 |
| Normal-vs-Female |
7.227100E-04 |
| Male-vs-Female |
2.158200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.622200E-04 |
| Normal-vs-Age(41-60Yrs) |
2.003600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.278240E-01 |
| Normal-vs-Age(81-100Yrs) |
2.159600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.735600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.872100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.704400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.607200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.404600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.499600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.472200E-02 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
2.790300E-02 |
| Classical-VS-Normal |
1.83641000000012E-05 |
| Tall-VS-Follicular |
1.3935519405095E-12 |
| Tall-VS-Other |
1.337760E-02 |
| Tall-VS-Normal |
4.15909999995634E-06 |
| Follicular-VS-Other |
1.944990E-01 |
| Follicular-VS-Normal |
2.849700E-02 |
| Other-VS-Normal |
8.810200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.438600E-01 |
| Normal-vs-N1 |
1.002800E-03 |
| N0-vs-N1 |
3.519200E-03 |
|
|
